Search results
Lung cancer risks remain high for smokers who switch to vaping
UPI· 8 hours agoIf you've quit smoking and have switched to vaping instead, your odds for lung cancer won't fall as...
CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF...
WKRN Nashville· 1 day agoFood and Drug Administration (FDA) has granted Orphan Drug Designation to Cantex' azeliragon, a well-tolerated once-a-day pill, for the treatment of pancreatic ...
FDA rejects liver cancer drug combo, shares of Korean biotech tank
Endpoints News· 4 days agoKorean biotech HLB and its China-based partner Jiangsu Hengrui Pharmaceuticals said Friday that the...
AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
Zacks· 2 days agoThis new plant will be AstraZeneca's (AZN) first manufacturing facility for producing novel antibody drug conjugates from start to finish. It is scheduled to open in 2029.
Aktis to collaborate with Eli Lilly on cancer therapies
Reuters via Yahoo News· 13 hours agoThe Boston-based drug developer will use its proprietary technology along with Lilly's expertise in...
Lilly partners with Aktis, deepening radiopharma investment
BioPharma Dive via Yahoo Finance· 11 hours agoThe company’s lead candidate targets a protein called Nectin-4 that’s associated with bladder and...
FDA Approves New Drug for Deadly Lung Cancer
Alaska Superstation· 5 days agoThe U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer.
F.D.A. Approves Drug for Persistently Deadly Form of Lung Cancer
New York Times· 5 days agoDrug Administration on Thursday approved an innovative new treatment for patients with a form of...
AstraZeneca to Build $1.5 Billion Cancer Drug Plant in Singapore
Bloomberg· 2 days agoHave a confidential tip for our reporters? AstraZeneca Plc plans to build a $1.5 billion...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 17 hours agoSanta Barbara, CA, May 21, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of breakthrough cancer drugs that will use the body’s immune system to ...